Psychedelics Round Table
One King West, Top Floor (Turn Right of the Elevator Bay till the end of the Hall)
Toronto, ON, Canada
Ontario
43.653226
-79.3831843
Description
Connecting the most innovative scientific minds across the globe for Research, Patient Awareness Deal Making & Industry Growth.
The Psychedelics Society facilitates transactions among the Scientists, Psychiatrists, Investors, medical professionals, investors, Corporations and aims to build a Psychedelics Society to accelerate the industry growth.
Meet Our Participants:
Kelsey Ramsden, MINDCURE Co-Founder & CEO
Kelsey has over 15 years of experience founding, scaling, and operating innovative companies across Canada and the Caribbean. She has built multiple 8-figure businesses from the ground up and has twice been named Canada’s Top Female Entrepreneur. Kelsey also serves on the Entrepreneurship Council for the University of Western Ontario, where she is also a faculty member teaching Design Thinking. Kelsey holds an MBA from the Richard Ivey School of Business at the University of Western Ontario. She is an accomplished keynote speaker and published author.
Sanjay Singhal, Founder, Audiobooks.com
Sanjay Singhal is a Canadian, Tech Entrepreneur and author best known for founding and selling Audiobooks.com. He created the 500 Startups Canada fund in 2016 and actively remains an ongoing investor in over 20 startups. His memoir “Zero to Tesla,” published in 2018 chronicles the whole improbable journey.
In 2018 he stepped into the Hospitality industry with the opening of his first cocktail lounge Coffee Oysters Champagne. With a French flare to it's menu, it has successfully been recognized as the largest and most accessible champagne bar in the city. This venture was followed by the opening of Marked, a South American inspired restaurant with a focus on wood-burning cuisine. Both are located in the heart of Toronto’s Entertainment District.
These days Sanjay's passion and attention lies in philanthropy. He launched the Nikean Foundation in 2019 to fund mental health research, focusing on novel psychedelic therapies to treat mental disorders including anorexia, depression, and PTSD. The Nikean Foundation currently funds research trials in Canada, the UK, and the US.
David Badcock, CEO, Drug Science
David Badcock is the Chief Executive Officer of Drug Science, the leading independent scientific body on drugs in the UK, working to provide clear, evidence-based information without political or commercial interference. Previously David held strategic positions in the substance misuse treatment sector for over 15 years. During this time, he has met and worked with thousands of individuals who have turned their lives around to lead healthy, successful lives free from the burden of drug addiction. He was previously the Chief Executive Officer of Mainliners, a national drug treatment organization focusing on harm reduction and blood borne viruses. David has been a committee member for the Cambridge Ethnic Community Forum, Chair of The Alliance (supporting people who receive prescribed medication for drug dependency), and Scientific Committee member for the influential London Joint Working Group for Substance Misuse and Hepatitis C. David specializes in creating unique partnerships with organizations and companies who share a joint vision to help the most marginalized and vulnerable members of our communities.
Ronan Levy, Executive Chairman, Field Trip Health Ltd.
Believing that you should never hesitate to trade your cow for a handful of magic beans, Ronan has built a career out of doing things that others say can't be done. Ronan started his career as a securities lawyer at Blake, Cassels & Graydon LLP but left after realizing he was much too creative for the profession of law. Since then, Ronan has helped launch business across a number of industries from gold, to cannabis, and, most recently, in psychedelics where he is a Co-founder and the Executive Chairman of Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP), a global leader in the development of psychedelic therapies. When not being thoroughly incorrigible, Ronan lives in Toronto with his wife and two children.
Field Trip Health Ltd.
Brandon Goode, Entrepreneur & Researcher
Brandon is an entrepreneur and consultant in the psychedelic space. His current projects focus on consumer-oriented applications of psychedelics, paving an alternative route to traditional medicalization. Previously, he worked at Field Trip Health as Director of Strategic Partnerships and at Novo Nordisk in Patient Access.
Richard Skaife, Co-Founder & Partner, The Conscious Fund
Co-Founder & Partner at The Conscious Fund: Over a decade of experience in venture capital gained as a partner in European tech VC and also as the CEO of a ventures incubator. He is a pioneer in mental health: he was the creator of Digipill, a multi-million downloaded mental wellness product; co-creator of the world’s largest dreaming experiment - Dream:ON - alongside Professor Richard Wiseman; he serves as Chair of Microdose on the business of psychedelics and as an advisor to The Psychedelic Medicine Association & Hive a global network of psychedelic clinics.
Tatiana Zdyb, Ph.D., M.A., C. Psych, Chief Medical Officer, Beatrice Society Inc.
Dr. Zbyb is a clinical psychologist, founder of the Zdyb Centre for Health Promotion and MindSetting. She completed her Ph.D. in Health and Rehabilitation Sciences at the University of Western Ontario and has been practicing psychotherapy for 17 years. In addition to publishing a theory of resilience she created the TRIP protocol for psychedelic-enhanced psychotherapy. She is actively engaged in testing its efficacy with various adult clinical populations. She is a part-time faculty member in the psychology department at King’s University College as well as chief academic officer at MindSetting Institute. Prior to this she worked as a medical consultant for Equitable Life of Canada, was the lead psychologist at St. Thomas Elgin General Hospital and was the head of group psychotherapy at the Student Development Centre at The University of Western Ontario.
Eric Vieira, Founder / Chief Marketing Officer, Beatrice Society Inc. , Founder / Chief Strategy Officer, King Ursa Inc.
Eric is a seasoned brand strategist and the co-founder of Beatrice Society: a Psychedelics and functional mushroom lifestyle brand that is focused on educating and healing both body and mind. Eric is also co-founder of King Ursa: a full service advertising agency that works on global brands within the B2C and B2B world. His specialization is focused on connections planning; while building operational efficiencies into the brands and companies he works on/with. Eric is also the co-founder of One Academy, a brand that was created in 2017 and today stands as one of Toronto’s must visited training facilities.
Simeon Schnapper, Managing Partner, JLS Fund
Simeon Schnapper is the founding Partner of JLS, a plant medicine fund His introduction to psychedelics came 30+ years ago in Chicago where he studied with Dr. Robert E.L. Masters and Jean Huston Ph.D. who authored the seminal book The Varieties of Psychedelic Experience: The Classic Guide to the Effects of LSD on the Human Psyche – one of the most important books written on the effects of LSD on the human psyche. As a curious teenager entering the space, searching for greater meaning in life he quickly learned about all the mental health indications that could be alleviated by coupling these molecules with psychotherapy or protocols millennia old from indigenous cultures. Later, he immersed himself in the Amazon with various ayahuasqueros and syncretic churches which showed him the power and efficacy of plant medicines; now becoming mainstream and medicalized. As a life-long student of Psychedelics he has a keen awareness of the cultural, regulatory and the nascent venture landscape of the mushrooming industry. As the president of the Hinman Foundation he formulated the vision and led all efforts on the ground in Tibet, Nepal, Myanmar, India, Mongolia and Bhutan. The foundation was able to support community-based organizations in several forest cultures where plant medicines are inseparable from everyday life and also oversaw grants which included a study on the Psychological and Cognitive Effects of Long-Term Peyote Use and the efficacy of hallucinogens for treating substance dependence. Simeon co-founded the High Art Collective in 2008 the world’s first Psychedelic Art Gallery and Marijuana Dispensary praised as a paradigm shift at the very beginning of the end of prohibition. Simeon advises several psychedelic and impact startups, is an Aspen Institute Fellow and a member of the New York Mycology Society. Born into a Peace Corps family, his early life was spent on assignment overseas where the ethos of exploration and helping others became deeply ingrained in his belief system.
Sa’ad Shah, Co-founder of Noetic
Sa’ad Shah is the co-founder of Noetic, a curiosity company dedicated to supporting early-stage psychedelic investments, mental-health, and human potential through initiatives in venture capital, media and education. He has spent 25 years in the investment management industry, including as managing director at The Carlyle Group. He is also a member of MENSA, Board Member of Necessary Angel Theatre (Toronto), and a member of the Council of Advisors to The Wende Museum (LA). Sa’ad graduated with a B.A. in Economics & Political Science from Columbia University. He is the proud father of two daughters and lives in Toronto.
Dr. Joseph A. De Leo, Ph.D., C.Psych, Clinical & Rehabilitation Psychologist
Dr. Joseph A. De Leo, Ph.D., C.Psych. is a dual licensed Clinical and Rehabilitation Psychologist with the College of Psychologists of Ontario and New York State Education Department. He received his PhD in Clinical Psychology from the University at Albany and completed a clinical internship at the Medical University of South Carolina (MUSC) as well a postdoctoral research at the University of North Carolina (UNC).
Joseph specializes in areas related to the assessment and treatment of addictions, trauma, and chronic pain conditions. He has extensive experience providing clinical and rehabilitation services in a variety of settings (i.e., hospitals, private and community-based practices), including supervising students and professional practice members, as well as teaching and providing consultation to health care organizations and Universities alike.
More recently, Dr. De Leo completed a Certificate in Psychedelic Assisted Therapies and Research (CPTR) at the California Institute of Integral Studies (CIIS). As part of his training, he received mentorship from pioneers in the field including Dr. Jeff Guss as well as consultation with Dr. Bill Richards and Dr. Charles Raison. Further, he has engaged in specialized training, including MAPS-based MDMA-Assisted Psychotherapy for PTSD with Annie and Michael Mithoefers as well as completed ketamine-assisted psychotherapy trainings with local practitioners.
Dr. De Leo maintains several active consultation groups, including with psychologists and registered psychotherapists, physical rehabilitation specialists, as well as psychedelic practitioners. He actively coordinates and participates in mixed gendered and men's support groups, which emphasize the importance of emotional awareness, openness, and honesty.
To date, Dr. De Leo has published more than a dozen peer-reviewed articles and book chapters, including recently in the Journal of Psychedelic Studies and Journal of Psychoactive Drugs. Also, he has served as the Director of Clinical Therapy at the first psychedelic-enhanced psychotherapy centre in Canada and is now focused on establishing a community-based psychedelic network of accessible health care services.
Together, along with Dr. Mitch Earleywine, he co-developed Integrative Ketamine Enhanced Psychotherapy (IKEP; De Leo & Earleywine, 2019) - currently being evaluated with his clinical team at the Centre for Compassionate Care.
Tentative & Evolving Schedule:
4:00PM to 4:15PM: Meet and Greet
4:15PM: Opening Remarks
4:20PM: 2 minute introductions from our 5 Co-Hosts
4:30PM: Science and Research Update
4:50PM: Industry Stigma / Regulation
5:15PM: 20 second introductions from all participants
5:30PM: Industry Gaps - where are the opportunities for the entrepreneurs?
6:00PM: Status of Capital Markets
6:30PM: Wine and Networking
7:00PM: Conclusion of roundtable
This listing has no upcoming events
Start:
2021-09-16T16:00:00-04:00
End:
2021-09-16T19:00:00-04:00
Category
Social
Tickets
Online Ticket
199.0
USD
10
Early Bird Ticket (Physical Ticket ie- Toronto attendance)
250.0
USD
10
Service Provider Ticket
500.0
USD
1
